Zacks Investment Research upgraded shares of Israel Chemicals (NYSE:ICL) from a sell rating to a hold rating in a report issued on Thursday morning, Zacks.com reports.

According to Zacks, “Israel Chemicals Ltd. is a manufacturer of specialty fertilizers and specialty phosphates, flame retardants and water treatment solutions. It operates primarily in three markets: agriculture, food and engineered materials. The Company’s products include bromine specialty chemicals, potash, phosphate fertilizers, and specialty performance and industrial products. It markets its products primarily in Israel, Europe, and the Americas. Israel Chemicals Ltd. is headquartered in Tel Aviv, Israel. “

Separately, Barclays began coverage on Israel Chemicals in a report on Thursday, January 16th. They set an equal weight rating on the stock.

Shares of NYSE:ICL traded down $0.01 during midday trading on Thursday, hitting $4.11. 133,213 shares of the stock were exchanged, compared to its average volume of 183,991. The stock has a market capitalization of $5.52 billion, a price-to-earnings ratio of 10.54, a P/E/G ratio of 1.04 and a beta of 0.95. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.84 and a current ratio of 1.51. The business’s 50-day moving average price is $4.44 and its 200 day moving average price is $4.67. Israel Chemicals has a 12 month low of $3.85 and a 12 month high of $5.73.

Israel Chemicals (NYSE:ICL) last released its quarterly earnings results on Thursday, February 13th. The basic materials company reported $0.04 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.04. The company had revenue of $1.11 billion for the quarter. Israel Chemicals had a return on equity of 13.82% and a net margin of 9.13%. As a group, sell-side analysts expect that Israel Chemicals will post 0.39 EPS for the current year.

Institutional investors have recently bought and sold shares of the stock. Russell Investments Group Ltd. lifted its stake in shares of Israel Chemicals by 92.1% in the third quarter. Russell Investments Group Ltd. now owns 433,065 shares of the basic materials company’s stock worth $2,151,000 after acquiring an additional 207,646 shares during the period. CWM Advisors LLC acquired a new position in shares of Israel Chemicals in the fourth quarter worth approximately $70,000. 1492 Capital Management LLC acquired a new position in shares of Israel Chemicals in the third quarter worth approximately $109,000. Parallel Advisors LLC lifted its stake in shares of Israel Chemicals by 126.1% in the third quarter. Parallel Advisors LLC now owns 7,364 shares of the basic materials company’s stock worth $37,000 after acquiring an additional 4,107 shares during the period. Finally, Signaturefd LLC lifted its stake in shares of Israel Chemicals by 63.5% in the third quarter. Signaturefd LLC now owns 21,451 shares of the basic materials company’s stock worth $107,000 after acquiring an additional 8,332 shares during the period. 5.62% of the stock is currently owned by institutional investors.

Israel Chemicals Company Profile

Israel Chemicals Ltd. operates as a specialty minerals and chemicals company worldwide. It operates in four segments: Industrial Products, Potash, Phosphate Solutions, and Innovative Ag Solutions (IAS). The Industrial Products segment produces bromine out of a solution that is a by-product of the potash production process, as well as bromine-based compounds; produces various grades of potash, salt, magnesium chloride, and magnesia products; and produces and markets phosphorous-based flame retardants and other phosphorus-based products.

Read More: What is a Buy-Side Analyst?

Get a free copy of the Zacks research report on Israel Chemicals (ICL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Israel Chemicals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Israel Chemicals and related companies with MarketBeat.com's FREE daily email newsletter.